Evaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021

Simple item page
dc.coverageGeneva
dc.creatorWorld Health Organization
dc.date2021-03-23T14:26:44Z
dc.date2021-03-23T14:26:44Z
dc.date2021-03-23
dc.date.accessioned2026-08-03T11:50:26Z
dc.descriptionviii, 58 p.
dc.descriptionThe Portuguese version is published by PAHO: https://iris.paho.org/handle/10665.2/54793
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.identifierWHO/2019-nCoV/vaccine_effectiveness/measurement/2021.1
dc.identifierhttps://iris.who.int/handle/10665/340301
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/248767
dc.languageEnglish
dc.languageРусский
dc.languagePortuguês
dc.languageen
dc.languageru
dc.languagept
dc.publisherWorld Health Organization
dc.rightsCC BY-NC-SA 3.0 IGO
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/3.0/igo
dc.rightsWorld Health Organization
dc.subjectCOVID-19
dc.subjectCOVID-19 Vaccines
dc.subjectBetacoronavirus
dc.subjectDisease Outbreaks
dc.subjectGuideline
dc.subjectVaccines
dc.subjectImmunity, Heterologous
dc.titleEvaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021
dc.typeTechnical Documents

Files

Collections

WHO IRIS